A method for preparing high-purity troxerutin
By dissolving troxerutin in methanol and N,N-dimethylacetamide and then crystallizing it, followed by further crystallization with methanol and water, the problems of low purity and difficulty in removing impurities in existing technologies have been solved, enabling the preparation and industrial production of high-purity troxerutin.
Patent Information
- Application Number
- CN202510628126.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-15
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are difficult to use to prepare high-purity troxerutin, especially to effectively remove the unknown impurities of RRT1.57. Furthermore, conventional methods may lead to impurity enrichment. Existing processes are cumbersome and costly, making them unsuitable for industrialization.
Crude troxerutin was dissolved in methanol and N,N-dimethylacetamide, and a primary purified product was obtained by crystallization. The purified product was then dissolved in methanol and water and crystallized again to obtain high-purity troxerutin. The dissolution and crystallization conditions were controlled to improve the purity.
The preparation of high-purity troxerutin was achieved, with a product purity of ≥96%, high yield, and suitability for industrial production. It also effectively removed the RRT1.57 impurity.
Smart Images

Figure CN123106783A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pharmaceutical synthesis technology, and specifically relates to a method for preparing high-purity troxerutin. Background Technology
[0002] Troxerutin, an anticoagulant and thrombolytic agent, is also known as vitamin P4, hydroxyethyl rutin, vinpocetine, and troxerutin. Its chemical name is 3',4',7-tris-[O-(2-hydroxyethyl)-5-hydroxyflavone-3]-rutin; its chemical formula is C2. 33 H 42 O 19 It can inhibit platelet aggregation and prevent thrombosis. Simultaneously, it can counteract vascular damage caused by serotonin and bradykinin, increase capillary resistance, and reduce capillary permeability, thus preventing edema caused by increased vascular permeability. It has a significant protective effect against acute ischemic brain injury. Troxerutin is a semi-synthetic flavonoid compound produced by the hydroxyethylation of rutin. It inhibits erythrocyte and platelet aggregation, prevents thrombosis, increases blood oxygen content, improves microcirculation, and promotes angiogenesis to enhance collateral circulation.
[0003]
[0004] Troxerutin is a semi-synthetic active pharmaceutical ingredient. Its raw material, rutin, is a plant extract. Because rutin has low purity, troxerutin also has low purity. The 2020 edition of the Chinese Pharmacopoeia stipulates that the purity of oral grade troxerutin is ≥80%, and the purity of injectable grade troxerutin is ≥88%.
[0005] Li Lingzhi et al. reported a method for preparing troxerutin in the August 2003 issue of the Journal of Shanxi Medical University, 34(4). The method used rutin as raw material, ethylene oxide as hydroxyethylating agent, and sodium hydroxide as catalyst. The crude troxerutin obtained had a content of 75%, and the content reached about 92% after purification. Although the method is relatively simple, the purity of the product is low and it failed to reach more than 95%.
[0006] Li Yang et al. reported in the June 2019 issue of *Chemical Research and Application*, Volume 31, No. 6, that they used commercially available rutin as a raw material. After reacting with acetic anhydride and purifying, they obtained acetylated rutin, which was then hydrolyzed to obtain high-purity rutin (purity ≥99%). This rutin was then used to prepare troxerutin, ultimately yielding troxerutin with a purity >98%. Although this method can produce troxerutin with high purity, the process is cumbersome, the overall yield is low, and the cost is high, making it unsuitable for industrialization.
[0007] The impurities in troxerutin have similar properties, and conventional purification methods are difficult to obtain high-purity products, making it difficult to increase the purity to above 95% while ensuring that the unknown single impurity is ≤1.0%. In particular, for the unknown impurity with RRT1.57, there is no reported effective purification method for this impurity in the existing technology. Conventional methods not only have difficulty purifying this impurity, but may even have an enrichment effect.
[0008] To facilitate the preparation of high-purity troxerutin, it is necessary to develop better purification methods to better control the quality of troxerutin and provide society with safe, effective, and quality-controlled medicines. Summary of the Invention
[0009] To address the problems existing in the prior art, the purpose of this invention is to provide a method for preparing high-purity troxerutin, comprising the following steps:
[0010] 1) Dissolve crude troxerutin in methanol and N,N-dimethylacetamide, and crystallize to obtain a primary refined product;
[0011] 2) The primary refined product was dissolved in methanol and water, and crystallization was performed to obtain the high-purity troxerutin;
[0012] According to an embodiment of the present invention, the HPLC purity of the crude troxerutin is less than 96%, for example less than 92%, for example 85%-90%.
[0013] According to an embodiment of the present invention, the mass fraction of RRT1.57 impurity in the crude troxerutin is greater than 1%, for example, 1%-2%.
[0014] According to an embodiment of the present invention, the mass-to-volume ratio of the crude troxerutin to the total volume of methanol and N,N-dimethylacetamide in step 1) is 1g:(8-20)mL, 1g:(10-15)mL, for example 1g:10mL, 1g:12mL, 1g:14mL, 1g:16mL, 1g:18mL.
[0015] According to an embodiment of the present invention, in step 1), the volume ratio of methanol to N,N-dimethylacetamide is (2-2.5):1, for example (2.1-2.3):1, such as 9:4, 87:38, 259:116.
[0016] According to an embodiment of the present invention, the mass-to-volume ratio of the crude troxerutin to the total volume of methanol and water in step 2) is 1g:(8-25)mL, 1g:(9-20)mL, for example 1g:10mL, 1g:12mL, 1g:14mL, 1g:16mL, 1g:18mL.
[0017] According to an embodiment of the present invention, in step 2), the volume ratio of methanol to water is (5-20):1, for example (8-19):1, such as 19:1, 16:3, 8:1.
[0018] According to an embodiment of the present invention, in steps 1) and 2), the crystallization step is to stir the system after solid precipitates out.
[0019] According to an embodiment of the present invention, in steps 1) and 2), the dissolution temperature is selected from 50-80°C, for example 65-70°C; and the dissolution time is selected from 0.1-3h, for example 1h.
[0020] According to an embodiment of the present invention, in steps 1) and 2), the crystallization temperature is selected from 15-30°C, for example 20-25°C; and the crystallization time is selected from 0.5-5h, for example 2h.
[0021] According to an embodiment of the present invention, the preparation method includes the following steps:
[0022] 1) Add crude troxerutin to methanol and N,N-dimethylacetamide, stir and heat until dissolved, then cool the filtrate to crystallize and obtain a primary purified product;
[0023] 2) Add the purified product to methanol and purified water, stir and heat until dissolved, then filter hot. Cool the filtrate to crystallize and obtain the high-purity troxerutin.
[0024] Beneficial effects
[0025] The refining process used in this invention is more convenient to operate, has a higher yield, and better impurity removal effect compared to existing processes. In particular, it has a refining effect on unknown impurities with RRT1.57, and the product purity is ≥96%, making it suitable for industrialization. Attached Figure Description
[0026] Figure 1 The HPLC chromatogram of Example 1;
[0027] Figure 2 The HPLC chromatogram for Example 2;
[0028] Figure 3 The HPLC chromatogram for Example 3;
[0029] Figure 4 This is the HPLC chromatogram of crude troxerutin. Detailed Implementation
[0030] The technical solution of the present invention will be further described in detail below with reference to specific embodiments. It should be understood that the following embodiments are merely illustrative and explanatory of the present invention, and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are covered within the scope of protection intended by the present invention.
[0031] Unless otherwise stated, the raw materials and reagents used in the following examples are commercially available products or can be prepared by known methods.
[0032] The crude troxerutin product of this invention is from Sichuan Xieli Pharmaceutical Co., Ltd.
[0033] Example 1
[0034] Add 50g of crude troxerutin (HPLC purity 88.758%, RRT 1.57, impurities 1.154%), 200ml of N,N-dimethylacetamide, and 450ml of methanol sequentially to the reaction flask. After the addition is complete, heat the system to 65-70℃ to dissolve the solid and stir the reaction for 1 hour. Then, cool the system to 20-25℃ and stir to induce crystallization. After solid precipitates in the system, stir the system at 20-25℃ to induce crystallization for 2 hours.
[0035] Filter, wash with 50 ml of methanol to obtain a yellow solid wet product;
[0036] Transfer the wet sample to a reaction flask, add 50 ml of purified water and 950 ml of methanol. After the addition is complete, heat the system to 65-70℃ to dissolve the solids and stir the reaction for 1 hour. Filter the solution hot, wash with 100 ml of methanol, cool the filtrate to 20-25℃, stir to precipitate crystals, and stir the system at 20-25℃ for 2 hours after solids precipitate.
[0037] Filter, wash with 50 ml of methanol to obtain a solid wet product;
[0038] The wet product was dried at 60±2℃ to constant weight to obtain 41 g of yellow solid, with a yield of 82%, HPLC purity of 96.750%, and RRT of 1.57 and impurities of 0.934%.
[0039] Example 2
[0040] Add 50g of crude troxerutin (HPLC purity 88.758%, RRT 1.57, impurities 1.154%), 152ml of N,N-dimethylacetamide, and 348ml of methanol sequentially to the reaction flask. After the addition is complete, heat the system to 65-70℃ to dissolve the solid and stir the reaction for 1 hour. Then, cool the system to 20-25℃ and stir to induce crystallization. After solid precipitates in the system, stir the system at 20-25℃ to induce crystallization for 2 hours.
[0041] Filter, wash with 50 ml of methanol to obtain a yellow solid wet product;
[0042] Transfer the wet sample to a reaction flask, add 75 ml of purified water and 400 ml of methanol. After the addition is complete, heat the system to 65-70℃ to dissolve the solids, stir and react for 1 hour. Filter the solution hot, wash with 100 ml of methanol, cool the filtrate to 20-25℃, stir to allow crystals to precipitate, and after solids precipitate in the system, stir the system at 20-25℃ to allow crystals to precipitate for 2 hours.
[0043] Filter, wash with 50 ml of methanol to obtain a solid wet product;
[0044] The wet product was dried at 60±2℃ to constant weight to obtain 40.5 g of yellow solid, with a yield of 81%, HPLC purity of 97.001%, and RRT of 1.57 and impurities of 0.838%.
[0045] Example 3
[0046] Add 50g of crude troxerutin (HPLC purity 88.758%, RRT 1.57, impurities 1.154%), 232ml of N,N-dimethylacetamide, and 518ml of methanol sequentially to the reaction flask. After the addition is complete, heat the system to 65-70℃ to dissolve the solid and stir the reaction for 1 hour. Then, cool the system to 20-25℃ and stir to induce crystallization. After solid precipitates in the system, stir the system at 20-25℃ to induce crystallization for 2 hours.
[0047] Filter, wash with 50 ml of methanol to obtain a yellow solid wet product;
[0048] Transfer the wet sample to a reaction flask, add 50 ml of purified water and 400 ml of methanol. After the addition is complete, heat the system to 65-70℃ to dissolve the solids, stir and react for 1 hour. Filter hot, wash with 100 ml of methanol, cool the filtrate to 20-25℃, stir to precipitate crystals, and after solids precipitate in the system, stir the system at 20-25℃ to precipitate crystals for 2 hours.
[0049] Filter, wash with 50 ml of methanol to obtain a solid wet product;
[0050] The wet product was dried at 60±2℃ to constant weight to give 39.5 g of yellow solid, yield 79%, HPLC purity 97.077%, RRT 1.57, impurities 0.437%.
[0051] Comparative Example
[0052] Refined troxerutin
[0053] Add 50g of crude troxerutin (HPLC purity 88.758%, RRT 1.57, impurities 1.154%), 475ml of methanol, and 25ml of purified water to the reaction flask in sequence. After the addition is complete, heat the system to 65-70℃ to dissolve the solid and stir the reaction for 1 hour. Then, cool the system to 20-25℃ and stir to induce crystallization. After solid precipitates in the system, stir the system at 20-25℃ to induce crystallization for 2 hours.
[0054] Filter, wash with 50 ml of methanol to obtain a yellow solid wet product;
[0055] Transfer the wet sample to a reaction flask, add 50 ml of purified water and 400 ml of methanol. After the addition is complete, heat the system to 65-70℃ to dissolve the solids, stir and react for 1 hour. Filter hot, wash with 100 ml of methanol, cool the filtrate to 20-25℃, stir to precipitate crystals, and after solids precipitate in the system, stir the system at 20-25℃ to precipitate crystals for 2 hours.
[0056] Filter, wash with 50 ml of methanol to obtain a solid wet product;
[0057] The wet product was dried at 60±2℃ to constant weight to give 42 g of yellow solid, yield 84%, HPLC purity 92.530%, RRT 1.57, impurities 1.436%.
[0058] The embodiments of the technical solution of the present invention have been described above by way of example. It should be understood that the protection scope of the present invention is not limited to the above embodiments. Any modifications, equivalent substitutions, improvements, etc., made by those skilled in the art within the spirit and principles of the present invention should be included within the protection scope of the claims of this application.
Claims
1. A method for preparing high-purity troxerutin, comprising the following steps: 1) Dissolve crude troxerutin in methanol and N,N-dimethylacetamide, and crystallize to obtain a primary refined product; 2) Dissolve the primary refined product in methanol and water, and crystallize to obtain the high-purity troxerutin.
2. The preparation method according to claim 1, characterized in that, The HPLC purity of the crude troxerutin is less than 96%, for example less than 92%, for example 85%-90%.
3. The preparation method according to claim 1 or 2, characterized in that, The crude troxerutin contains more than 1% by mass of RRT1.57 impurities, for example, 1%-2%.
4. The preparation method according to any one of claims 1-3, characterized in that, The mass-to-volume ratio of the crude troxerutin to the total volume of methanol and N,N-dimethylacetamide in step 1) is 1g:(8-20)mL, 1g:(10-15)mL.
5. The preparation method according to any one of claims 1-4, characterized in that, In step 1), the volume ratio of methanol to N,N-dimethylacetamide is (2-2.5):1, for example (2.1-2.3):
1.
6. The preparation method according to any one of claims 1-5, characterized in that, The mass-to-volume ratio of the crude troxerutin to the total volume of methanol and water in step 2) is 1g:(8-25)mL, 1g:(9-20)mL.
7. The preparation method according to any one of claims 1-6, characterized in that, In step 2), the volume ratio of methanol to water is (5-20):1, for example (8-19):
1.
8. The preparation method according to any one of claims 1-7, characterized in that, In steps 1) and 2), the crystallization step is to stir the system after solid precipitates out.
9. The preparation method according to any one of claims 1-8, characterized in that, In steps 1) and 2), the dissolution temperature is selected from 50-80℃, for example 65-70℃; the dissolution time is selected from 0.1-3h. Preferably, in steps 1) and 2), the crystallization temperature is selected from 15-30°C, for example 20-25°C; and the crystallization time is selected from 0.5-5h.
10. The preparation method according to any one of claims 1-9, characterized in that, The preparation method includes the following steps: 1) Add crude troxerutin to methanol and N,N-dimethylacetamide, stir and heat until dissolved, then cool the filtrate to crystallize and obtain a primary purified product; 2) Add the purified product to methanol and purified water, stir and heat until dissolved, then filter hot. Cool the filtrate to crystallize and obtain the high-purity troxerutin.
